Matrubials YC 申请

Summer 2021Active

Matrubials 在 Summer 2021 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Summer 2021
行业: HealthcareDrug Discovery and Delivery
团队规模: 4
状态: Active
已发布: 2021

创始人

Bruce GermanFounder
Carlito LebrillaFounder
David MillsFounder

Matrubials 做什么

Matrubials is an anti-infectives company, focused on human milk peptides as therapeutics to address antimicrobial resistance and modern diseases. Currently the global rise in severe bacterial infections and the drying pipeline of effective treatments are burdensome for healthcare and economics. Sculpted by evolution, milk, first food for the newborn, provides an exemplary solution to address the nutritive and protective challenges an infant is faced with. The anti-pathogenic molecules from milk can be developed into therapeutics geared towards all-age diseases. Our first indication is bacterial vaginosis, a bacterial dysbiosis related inflammation that results in recurrent infections, disruption of homeostasis and long-term clinical complications in women of reproductive age, including but not limited to preterm births, fertility issues and increased rates of STDs. Our next inflection point is the evaluation of rapidly acting and selective candidate peptides in pre-clinical host impact and early safety studies, which can aid clinical and portfolio development towards topical applications.

Matrubials 的 YC 申请，重建版

Y Combinator 申请

Matrubials，Summer 2021 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Matrubials

Describe what your company does in 50 characters or less.

Milk-inspired therapeutics for infectious diseases

What is your company going to make? Please describe your product and what it does or will do.

We are developing antimicrobial peptides derived from human milk to treat bacterial infections. Our lead program targets bacterial vaginosis, aiming to restore microbial balance and prevent recurrent infections and inflammation that affect women's reproductive health. These peptides act selectively to avoid disrupting beneficial bacteria and offer a novel treatment approach against antimicrobial resistance.

Where do you live now, and where would the company be based after YC?

We live and work in Davis, CA. After YC, the company will remain based here to leverage local research connections and our core scientific team.

Explain your decision regarding location.

Davis hosts our founders and is near key research institutions. Staying here maintains continuity in science and development and supports our focused approach on milk-based therapeutics.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 Matrubials 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 Matrubials 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Matrubials 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

Matrubials 是哪个 YC 批次的？

Matrubials 是 Y Combinator Summer 2021 批次的成员。

谁创立了 Matrubials？

Matrubials 由 Bruce German, Carlito Lebrilla, David Mills 创立。

Matrubials 做什么？

Developing milk-inspired therapeutics for infectious diseases

如何阅读完整的重建申请？

创建免费的 Round Funded 账户。YC Insights 中包含 Matrubials 的完整 26 个问题的版本，以及其他所有 YC 批次的公司信息。